Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study

Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros

Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Journal Issue: January
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Katerina Antoniou, Katerina Markopoulou, Argyrios Tzouvelekis, Athina Trachalaki, Eirini Vasarmidi, Jiannis Organtzis, Vasilios Tzilas, Evangelos Bouros, Georgia Kounti, Christina Rampiadou, Serafeim-Chrysovalantis Kotoulas, Fotini Bardaka, Eleni Bibaki, Evangelia Fouka, Georgios Meletis, Stavros Tryfon, Zoe Daniil, Despina Papakosta, Demosthenes Bouros. Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study. ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis
Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis
Year: 2019



Effectiveness of treatments for severe sepsis: a prospective multicentre observational study in Spanish ICUs
Source: Annual Congress 2009 - Severe sepsis and multiple organ failure
Year: 2009


Benefits of pulmonary rehabilitation in COVID-19 – a prospective observational cohort study
Source: Virtual Congress 2021 – Insights into rehabilitation and physiotherapy in COVID-19
Year: 2021


Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study
Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021
Year: 2022



Tiotropium discontinuation in patients with early-stage COPD: a prospective observational cohort study
Source: ERJ Open Res, 5 (1) 00175-2018; 10.1183/23120541.00175-2018
Year: 2019



Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
Source: ERJ Open Res, 4 (4) 00084-2018; 10.1183/23120541.00084-2018
Year: 2018



Characteristics and clinical management of IPF patients in Spain: prospective, observational, multicentric study (OASIS study).
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Economic impact of IPF exacerbations in Spain: prospective, observational, multicentric study (OASIS study)
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Use of bosentan for the treatment of pulmonary arterial hypertension in Spain: a multicenter, retrospective, observational study
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009

Comparison of Interferon gamma-1b (IFN-γ)and colcicine in the treatment of Idiopathic pulmonary fibrosis: preliminary results of a prospective, multicenter randomised study
Source: Eur Respir J 2002; 20: Suppl. 38, 599s
Year: 2002

Real-life data on the safety and tolerability of Pirfenidone versus Nintedanib in Idiopathic Pulmonary Fibrosis (IPF) patients: A single-centre retrospective study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


REALizing and improving management of COPD in China: A prospective observational study
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021


Characteristics of COPD patients from primary care enrolled in a prospective multicenter cohort study
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010


A prospective descriptive trial examining 421 Canadian COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 516s
Year: 2005

PEGASUS - the effects of commercial air travel on patients suffering from pulmonary hypertension - a prospective, multicenter, multinational study
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Observational, multicentre study on the epidemiology of haemoptysis
Source: Eur Respir J, 51 (1) 1701813; 10.1183/13993003.01813-2017
Year: 2018



Etiology and clinical characteristics of bronchiectasis in Taiwan: a multi-center cohort study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019


The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study
Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018
Year: 2019



Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021